Callaghan MU, Asikanius E, Lehle M, Oldenburg J, Mahlangu J, Uguen M, et al. Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3. Res Pract Thromb Haemost. 2022;6(6):e12782. https://onlinelibrary.wiley.com/doi/full/10.1002/rth2.12782
Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3.
By Peter Matlawa|2023-02-20T01:25:32+02:00February 20, 2023|2022: July to September|Comments Off on Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys(®) cortisol II assay: a pilot study.